Michael Dunne
Founder at ITERUM THERAPEUTICS PLC
Net worth: 175 181 $ as of 2024-03-30
Profile
Michael W.
Dunne is the founder of Iterum Therapeutics Plc, which was founded in 2015.
He is currently the Director of Iterum Therapeutics Plc.
He is also currently the Vice Chairman of Antimicrobials Working Group since 2018.
Additionally, he holds the position of Director at Iterum Therapeutics International Ltd.
and Chief Science Officer at Iterum Pharmaceuticals LLC.
He started working as the Chief Medical Officer at Gates Medical Research Institute in 2015.
In his former positions, he served as an Independent Non-Executive Director at Aviragen Therapeutics, Inc. He was also the VP & Head- Development for Infectious Disease at Pfizer Inc. from 2001 to 2009.
He held the position of Chief Medical Officer at Durata Therapeutics, Inc. from 2010 to 2014 and Vice President-R&D at Allergan Ltd.
(Ireland) from 2014 to 2015.
He is a member of the American College of Physicians, Inc., Infectious Diseases Society of America, and American Society for Microbiology.
He completed his undergraduate degree at Northwestern University and obtained his doctorate degree from The State University of New York.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
ITERUM THERAPEUTICS PLC
0.85% | 2023-12-21 | 113,754 ( 0.85% ) | 175 181 $ | 2024-03-30 |
Michael Dunne active positions
Companies | Position | Start |
---|---|---|
ITERUM THERAPEUTICS PLC | Founder | 2015-10-31 |
Iterum Pharmaceuticals LLC
Iterum Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Iterum Pharmaceuticals LLC manufactures pharmaceutical products. The company is headquartered in Chicago, IL. | Chief Tech/Sci/R&D Officer | - |
Antimicrobials Working Group
Antimicrobials Working Group Miscellaneous Commercial ServicesCommercial Services Antimicrobials Working Group is an American nonprofit company. The firm operates as an association of antimicrobials and diagnostics companies. The company says this about itself: AWG was founded in 2012 with the vision of utilizing collective power to improve the regulatory, investment, and commercial environment for emerging infectious disease companies. Today, AWG is comprised of thirteen antimicrobials companies: Acurx Pharmaceuticals, Inc., Cidara Therapeutics Inc., CorMedix Inc., Crestone, Inc., Entasis Therapeutics Inc., Iterum Therapeutics Ltd., Melinta Therapeutics LLC, Nabriva Therapeutics US Inc., Paratek Pharmaceuticals Inc., Qpex Biopharma, Inc., SCYNEXIS Inc., UTILITY therapeutics Ltd., and Venatorx Pharmaceuticals, Inc. | Director/Board Member | 2018-01-29 |
Iterum Therapeutics International Ltd.
Iterum Therapeutics International Ltd. Pharmaceuticals: MajorHealth Technology Iterum Therapeutics International Ltd. engages in the development of clinical-stage pharmaceutical products. The company was founded in 2015 and is headquartered in Dublin, Ireland. | Director/Board Member | - |
Gates Medical Research Institute | Chief Tech/Sci/R&D Officer | 2015-10-31 |
Former positions of Michael Dunne
Companies | Position | End |
---|---|---|
ALLERGAN PLC | Chief Tech/Sci/R&D Officer | 2015-08-31 |
DURATA THERAPEUTICS INC | Chief Tech/Sci/R&D Officer | 2014-10-31 |
PFIZER, INC. | Chief Tech/Sci/R&D Officer | 2008-12-31 |
Aviragen Therapeutics, Inc.
Aviragen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aviragen Therapeutics, Inc. engages in the discovery and development of direct-acting antivirals to treat infections. Its product candidates include vapendavir, an oral treatment for human rhinovirus infections in moderate-to-severe asthmatics; BTA074, a topical antiviral treatment for genital warts caused by human papillomavirus types 6 & 11; BTA585, an oral fusion protein inhibitor for the treatment of RSV-A and RSV-B infections; and laninamivir octanoate, a one-time, inhaled treatment for influenza A and B infections. The company was founded on November 8, 2012 and is headquartered in Alpharetta, GA. | Director/Board Member | - |
░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Michael Dunne
Northwestern University | Undergraduate Degree |
The State University of New York | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
PFIZER, INC. | Health Technology |
ITERUM THERAPEUTICS PLC | Health Technology |
Private companies | 10 |
---|---|
American College of Physicians, Inc. /Old/
American College of Physicians, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services American College of Physicians, Inc. operates as a medical-specialty organization. It is a national organization of internists and physician specialists who apply scientific knowledge and clinical expertise to the diagnosis, treatment, and care of adults from health to complex illness. Its members include internists, internal medicine subspecialists, medical students, residents, and fellows. The company was founded in 1915 and is headquartered Philadelphia, PA. | Commercial Services |
Infectious Diseases Society of America
Infectious Diseases Society of America Miscellaneous Commercial ServicesCommercial Services The Infectious Diseases Society of America is a non-profit company that provides clinical practice guidelines development and guideline panelists for infectious diseases. The company is based in Arlington, VA and has subsidiaries in the United States. The company specializes in antimicrobial stewardship and have established Antimicrobial Stewardship Centers of Excellence. The CEO of the company is Christopher Busky. | Commercial Services |
American Society for Microbiology
American Society for Microbiology Miscellaneous Commercial ServicesCommercial Services The American Society for Microbiology (ASM) is the oldest and largest single life science membership organization in the world. The private company is based in Washington and has subsidiaries in the United States. ASM's membership has grown from 59 scientists in 1899 to more than 39,000 members today, with more than one third located outside. The members represent 26 disciplines of microbiological specialization plus a division for microbiology educators. | Commercial Services |
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
Aviragen Therapeutics, Inc.
Aviragen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aviragen Therapeutics, Inc. engages in the discovery and development of direct-acting antivirals to treat infections. Its product candidates include vapendavir, an oral treatment for human rhinovirus infections in moderate-to-severe asthmatics; BTA074, a topical antiviral treatment for genital warts caused by human papillomavirus types 6 & 11; BTA585, an oral fusion protein inhibitor for the treatment of RSV-A and RSV-B infections; and laninamivir octanoate, a one-time, inhaled treatment for influenza A and B infections. The company was founded on November 8, 2012 and is headquartered in Alpharetta, GA. | Health Technology |
Iterum Pharmaceuticals LLC
Iterum Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Iterum Pharmaceuticals LLC manufactures pharmaceutical products. The company is headquartered in Chicago, IL. | Health Technology |
Antimicrobials Working Group
Antimicrobials Working Group Miscellaneous Commercial ServicesCommercial Services Antimicrobials Working Group is an American nonprofit company. The firm operates as an association of antimicrobials and diagnostics companies. The company says this about itself: AWG was founded in 2012 with the vision of utilizing collective power to improve the regulatory, investment, and commercial environment for emerging infectious disease companies. Today, AWG is comprised of thirteen antimicrobials companies: Acurx Pharmaceuticals, Inc., Cidara Therapeutics Inc., CorMedix Inc., Crestone, Inc., Entasis Therapeutics Inc., Iterum Therapeutics Ltd., Melinta Therapeutics LLC, Nabriva Therapeutics US Inc., Paratek Pharmaceuticals Inc., Qpex Biopharma, Inc., SCYNEXIS Inc., UTILITY therapeutics Ltd., and Venatorx Pharmaceuticals, Inc. | Commercial Services |
Iterum Therapeutics International Ltd.
Iterum Therapeutics International Ltd. Pharmaceuticals: MajorHealth Technology Iterum Therapeutics International Ltd. engages in the development of clinical-stage pharmaceutical products. The company was founded in 2015 and is headquartered in Dublin, Ireland. | Health Technology |
Gates Medical Research Institute | |
Durata Therapeutics, Inc.
Durata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Durata Therapeutics, Inc. develops and commercializes novel therapeutics for infectious diseases and acute illnesses. The company was founded on November 4, 2009 and is headquartered in Chicago, IL. | Health Technology |
- Stock Market
- Insiders
- Michael Dunne